Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1379415 | Bioorganic & Medicinal Chemistry Letters | 2005 | 5 Pages |
Abstract
Starting from the potent and selective but poorly brain penetrant 5-HT6 receptor antagonist SB-271046, a successful strategy for improving brain penetration was adopted involving conformational constraint with concomitant reduction in hydrogen bond count. This provided a series of bicyclic heteroarylpiperazines with high 5-HT6 receptor affinity. 5-Chloroindole 699929 combined high 5-HT6 receptor affinity with excellent brain penetration and also had good oral bioavailability in both rat and dog.
Graphical abstractThe selective, brain penetrant and orally bioavailable 5-HT6 receptor antagonist 12 (699929) is described.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Mahmood Ahmed, Michael A. Briggs, Steven M. Bromidge, Tania Buck, Lorraine Campbell, Nigel J. Deeks, Ashley Garner, Laurie Gordon, Dieter W. Hamprecht, Vicky Holland, Christopher N. Johnson, Andrew D. Medhurst, Darren J. Mitchell, Stephen F. Moss,